Karin Wuertz-Kozak
Professor
Karin Wuertz-Kozak
Professor
Education
BS, MS, University of Regensburg (Germany); Ph.D., University of Ulm (Germany); MBA, University of Cumbria (UK)
Bio
Dr. Wuertz-Kozak is a pharmacist by training, with a Ph.D. in Human Biology from the University of Ulm in Germany and an MBA in Leadership and Sustainability from the University of Cumbria in the UK. Following a postdoctoral fellowship at the University of Vermont, she became a group leader at the University of Zurich and ETH Zurich in Switzerland. She later served as an Assistant Professor at ETH Zurich for three years, where she received the prestigious Swiss National Science Foundation Professorship Award. In 2019, Dr. Wuertz-Kozak was appointed the Kate Gleason Endowed Professor of Biomedical Engineering at RIT, where she currently holds the Harvey J. Palmer Endowment and leads the Tissue Regeneration and Mechanobiology Laboratory.
An AIMBE Fellow, Dr. Wuertz-Kozak has secured over $8 million in research funding from prominent funding agencies in the U.S. and Europe, including NSF, NIH, and CDMRP. Her lab focuses on understanding the cellular mechanisms underlying pathological processes, particularly inflammation and fibrosis, to develop innovative therapies for tissue regeneration and pain reduction. By integrating biomaterials, biologics, genome engineering, and mechanical stimulation, her work bridges basic science and clinical application to improve patient outcomes.
Select Scholarship
Bermudez-Lekerika P, Crump KB, Wuertz-Kozak K, Le Maitre CL, Gantenbein B: Sulfated hydrogels as primary intervertebral disc cell culture systems. Gels 2024, 10(5), 330
Bjorgvinsdottir O, Ferguson S, Gudjonsson T, Snorradottir B, Wuertz-Kozak K: The Influence of Physical and Spatial Substrate Characteristics on Endothelial Cells. Materials Today Bio 2024, 26: 101060
Cazzanelli P, Lamoca M, Hausmann ON, Mesfin A, Puvanesarajah V, Hitzl W, Haglund L, Wuertz-Kozak K: Exploring the Impact of TLR-2 Signaling on miRNA Dysregulation in Intervertebral Disc Degeneration. Advanced Biology 2024, 28:e2300581
Ceballos-Santa MC, Sierra A; Zalbidea IK, Lazarus E, Marin-Montealegre V, Ramesh S, Iglesias P, Wuertz-Kozak K, Rivero IV: Aloe vera-based Biomaterial Ink for 3D Bioprinting of Wound Dressing Constructs. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2024, 112(2), e3579
Bitterli T, Schmid D, Ettinger L, Krupkova O, Bach FC, Tryfonidou MA, Meij BP, Pozzi P, Steffen F, Wuertz???Kozak K, Smolders LA: Targeted screening of inflammatory mediators in spontaneous degenerative disc disease in dogs reveals an upregulation of the tumor necrosis superfamily. JOR Spine 2024, 7 (1) e1292
Schoeller J, Wuertz-Kozak K, Ferguson SJ, Rottmar M, Elbs-Glatz Y, Avaro J, Chung M, Rossi RM: Ibuprofen-loaded electrospun poly (ethylene-co-vinyl alcohol) nanofibers for wound dressing applications. Nanoscale Advances 2023, 5 (8) 2261-2270
Currently Teaching
In the News
-
September 1, 2023
RIT researchers pioneer solutions for degenerative disc disease and back pain
Researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S. Using state-of-the-art gene editing technology in mesenchymal stem cells, the researchers will add to the growing field of regenerative medicine, the process of producing cellular therapies to alleviate pain and lack of mobility.
-
December 22, 2022
Leading spinal researcher develops new tissue regeneration approaches for back pain
Karin Wuertz-Kozak described her lab test equipment as a gym for cells. Stretching and compressions tests using bioreactors—her lab equipment—can make a difference in understanding how cells respond to mechanical cues and how that affects disease progression, specifically for spinal disc degeneration, common to millions of Americans.
-
October 20, 2022
Biomedical engineering researcher awarded grant to study chronic skin fibrosis
More collagen in the human body is not always good, and Professor Karin Wuertz-Kozak is investigating how disease progresses because of the increase in this important protein.